Reduced expressed SPARCL1 has been related to favourable prognosis in colorectal cancer, while its upregulation in tumour vessel endothelial cells has been linked to better survival in colorectal carcinoma.15 The gene discussed is SPARCL1; the disease is colorectal cancer.